Hello;
Undoubtedly, Japan is the country with the highest level of medical care in Asia, and it only takes about three hours to go to Tokyo Narita Airport in Japan from Beijing. Japan's medical costs are also moderate, cancer treatment in Japan costs about 250,000 yuan, the overall medical price is twice as much as in the country, is one-third of the United States. Cancer treatment in Japan is a system of cancer prevention and treatment research developed independently in Japan. It leads the world in cancer diagnosis and treatment, especially in the discovery of early-stage cancer, and holds the world record for cancer discovery - the discovery of early-stage cancer below the millimeter level. This type of examination can detect the vast majority of possible early stage cancers or super early stage cancers at the millimeter and micrometer level below 10mm. Whereas world-level cancer screening can only detect cancers over 15mm, in China, what can be detected by the instrument is probably a few centimeters or more of mid- to late-stage cancer cells.
Here are the rankings of cancer treatment hospitals in Japan
Japan Cancer Research Ariake Hospital is the top-ranked cancer specialty hospital in Japan and one of the top-ranked cancer centers in the world. Located in Koto-ku, Tokyo, Cancer Research Ariake Hospital is consistently ranked as the best in Japan for the treatment of stomach, colon, breast, and prostate cancers, as well as one of the top three hospitals in Japan for the treatment of other adult cancers, such as liver and lung cancers. Since its establishment, it has always been committed to the research and development of cutting-edge cancer treatment technologies, and with its world-advanced diagnostic and treatment technologies, it has been driving innovation in the field of cancer treatment technologies in Japan and the world.
The National Cancer Research Center (NCRC) was established in 1961 and is located in the heart of Tokyo. The National Cancer Research Center is a comprehensive center for cancer treatment, cancer prevention and research. It is the second most specialized cancer hospital in Japan after Cancer Research Ariake Hospital. The National Cancer Center is divided into the East Hospital and the Central Hospital. The East Hospital is equipped with the world's most advanced proton therapy equipment, which is what makes the National Cancer Center ahead of Cancer Research Ariake Hospital. Because of the proton therapy equipment, the National Cancer Center has a significant advantage in the treatment of cancers such as skull base tumors, nose and sinus tumors, nasopharyngeal cancer, early prostate cancer, early lung cancer, and liver cancer.
Hyogo Prefectural Particle Therapy Center, established in 2001, is the only medical facility in the world that can perform both proton and heavy particle therapy, and is known for its remarkable treatment results. Since its opening, the center has treated over 4,500 patients, and currently receives over 100 patients per day. Since February 2009, the center has also begun treating pancreatic cancer, and more than 210 patients have been treated. So far the center has received overseas patients from Thailand, China, South Korea and Italy, and has accumulated experience in working with local medical institutions.
Professor Makoto Hiraoka, who leads the Department of Radiation Therapy at Kyoto University Hospital, is a renowned expert in cancer radiation therapy and a pioneer in high-precision radiation therapy. He started clinical research on high-precision radiation therapy for prostate cancer, such as localized radiation therapy for isolated lung tumors and IMRT therapy, at a very early stage in China. With the ultimate goal of curing all cancers without surgery and allowing patients to enjoy a normal life, he has successfully developed new irradiation therapy equipment that can accurately irradiate lesions based on respiratory movements. For prostate cancer, we use "pre-hormone therapy + IMRT" with low risk of side effects and good results.
The University of Tsukuba Hospital Proton Therapy CenterThe University of Tsukuba was the first in Japan to conduct clinical research on proton therapy in 1983, and its Proton Therapy Medical Utilization Research Center, which opened in September 2001, is the only proton therapy facility at a university hospital in Japan. The number of cases treated, including treatment at the High Energy Accelerator Research Facility prior to the opening of the Center, is approximately 3,000. The largest number of cases is liver cancer, with nearly 1,000 cases, followed by lung cancer and prostate cancer. The Breathing Synchrotron Radiation Therapy method, which has become an international standard, is an irradiation method developed at the center, and the introduction of this technology has made it possible to perform proton beam therapy for liver and lung cancers.
Kameda Medical Center, which is the collective name for the Kameda Clinic and Kameda Rehabilitation Hospital centered on Kameda General Hospital, was the first in Japan to receive accreditation from the Joint Commission International (JCI), the U.S.-based accrediting body for international healthcare facilities, in 2009. We have been actively accepting patients from overseas for a long time, and our International Relations Department is responsible for arranging appointments for medical treatment, contacting insurance companies, and responding to inquiries about study tours and training programs, as well as providing hospitality afterward. The Center has been able to enhance the environment for receiving foreign patients, and the number of consultations from overseas has been increasing year by year, with approximately 1,200 foreign patients received each year. Cancer treatment at the center is characterized by the timely and proper combination of the three standard therapies of surgery, radiotherapy and chemotherapy by a team of various specialists. The center utilizes a high-level team approach led by one of the few cancer specialists in Asia. In addition, the center utilizes the strengths of a general hospital to provide comprehensive, safe, and effective treatment for cancer patients with complications such as heart disease, cerebrovascular disease, and respiratory disease, as well as for elderly cancer patients who suffer from multiple complications, through consultation and close collaboration with specialists from each specialty.
The Proton Therapy Center at Hokkaido University Hospital is developing proton therapy equipment, which is leading the world in cancer radiotherapy technology, in collaboration with Hokkaido University, a national university, and Hitachi, Ltd. under a research support system that promotes cutting-edge research and development, with the goal of creating the world's top "state-of-the-art technology research and development support program". Our Proton Therapy Center is the first in the world to introduce the most advanced proton therapy equipment, the "Dot Scanning Proton Beam Irradiator", which can precisely irradiate proton beams in 360 degrees for active cancers, and is capable of treating patients of all ages (from infants to the elderly) with the Dot Scanning Irradiator technology.
Chiba University Medical Center is recognized as a leading oncology hospital in Japan, with strong technical capabilities, and plays a central role as a medical institution by treating patients from all over Japan. In particular, it is active in the treatment of refractory cancers, and in the field of hepatobiliary and pancreatic surgery, it is committed to clinical and basic research while performing difficult surgeries. The number of cases treated is 11, the highest in Japan and the second highest in the world, and the results of treatment have won high praise from the medical community in Japan and abroad. It is one of the first hospitals in Japan to provide treatment for esophageal cancer. The hospital is committed to the research and development of tumor immunotherapy using NKT cells and has set up a clinical application center within the hospital, leading the world trend of immunotherapy. The hospital has been approved by the Ministry of Health, Labor and Welfare as a hospital that provides advanced medical treatment for difficult-to-treat cancers such as lung cancer, oral cavity cancer in the head and neck area, and laryngeal and pharyngeal head cancers, and has treated eight cancer patients.
Gunma Heavy Ion Beam Medical Center Gunma University opened the Gunma University Heavy Ion Beam Medical Research Center on June 1, 2005, with the goal of developing cutting-edge heavy ion beam therapy based on radiobiology and clinical research and the treatment technology necessary for its realization, and with the aim of smoothly advancing comprehensive research in heavy ion beam medicine. To date, Gunma University has played a pioneering role in the field of radiation oncology and nuclear medicine in Japan. In particular, it also plays an important role in training radiologists for radiation oncology treatment. Ten percent of all certified radiologists in Japan are from the University's Department of Radiation Medicine. The institution also maintains close collaborative relationships with the Institute of Radiation Medicine (IRM), a representative institution for the use of radiation in Japan, and the Japan Atomic Energy Research and Development Organization (JAERDO) Takasaki Institute of Quantum Applications (HARAKI-TAKASAKI).
The Duo Mutual Health Medical Center has launched a one-stop service for Chinese patients to receive cancer treatment in Japan - the Changsheng Rainbow Bridge International Medical Insurance. With its excellent and highly reputable services, it is the first medical residency visa status sponsorship organization in Japan, maintains close cooperation with more than 1,000 medical institutions in Japan, has a strong medical network resources, and is in the leading position in the industry to help overseas patients go to Japan's medical institutions to receive treatment.